• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Will the IRA squash new drugs? Those worries are likely exaggerated, studies say.

cafead

Administrator
Staff member
  • cafead   Aug 22, 2024 at 11:12: AM
via There’s no link between revenue and R&D from smaller biotechs, and that’s where most innovation comes from, according to new studies.

article source
 

<